Efflux Pump Inhibitors for Bacterial Pathogens: From Bench to Bedside

Overview

Journal Indian J Med Res

Specialty General Medicine

Date 2019 Jun 21

PMID 31219077

Citations 126

Authors

Atin Sharma

Vivek Kumar Gupta

Ranjana Pathania

Affiliations

Soon will be listed here.

Abstract

With the advent of antibiotics, bacterial infections were supposed to be a thing of past. However, this instead led to the selection and evolution of bacteria with mechanisms to counter the action of antibiotics. Antibiotic efflux is one of the major mechanisms, whereby bacteria pump out the antibiotics from their cellular interior to the external environment using special transporter proteins called efflux pumps. Inhibiting these pumps seems to be an attractive strategy at a time when novel antibiotic supplies are dwindling. Molecules capable of inhibiting these pumps, known as efflux pump inhibitors (EPIs), have been viewed as potential therapeutic agents that can rejuvenate the activity of antibiotics that are no longer effective against bacterial pathogens. EPIs follow some general mechanisms of efflux inhibition and are derived from various natural as well as synthetic sources. This review focuses on EPIs and identifies the challenges that have kept these futuristic therapeutics away from the commercial realm so far.

Citing Articles

Riverine antibiotic resistome along an anthropogenic gradient.

Wang G, Haenelt S, Correa F, da Rocha U, Musat F, Zhang J Front Microbiol. 2025; 16:1516033.

PMID: 40078550 PMC: 11897494. DOI: 10.3389/fmicb.2025.1516033.

Food substances alter gut resistome: Mechanisms, health impacts, and food components.

Liang Z, Liang Z, Hu H, Howell K, Fang Z, Zhang P Compr Rev Food Sci Food Saf. 2025; 24(2):e70143.

PMID: 40047321 PMC: 11884230. DOI: 10.1111/1541-4337.70143.

Multidrug efflux pumps of show selectivity for their natural substrates.

Mazza L, Bory A, Luscher A, Kloehn J, Wolfender J, Van Delden C Front Microbiol. 2025; 15():1512472.

PMID: 39850140 PMC: 11754269. DOI: 10.3389/fmicb.2024.1512472.

Defense mechanisms of against antibiotics: a review.

Punchihewage-Don A, Ranaweera P, Parveen S Front Antibiot. 2025; 3():1448796.

PMID: 39816264 PMC: 11731628. DOI: 10.3389/frabi.2024.1448796.

Phytochemical Analysis and Antimicrobial Activity of (Gaertn.) Roxb. and Retz. Fruit Extracts Against Gastrointestinal Pathogens: Enhancing Antibiotic Efficacy.

Tiwana G, Cock I, Cheesman M Microorganisms. 2025; 12(12.

PMID: 39770866 PMC: 11728670. DOI: 10.3390/microorganisms12122664.

References

Michalet S, Cartier G, David B, Mariotte A, Dijoux-Franca M, Kaatz G . N-caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors. Bioorg Med Chem Lett. 2007; 17(6):1755-8. DOI: 10.1016/j.bmcl.2006.12.059. View

Sharma S, Kumar M, Sharma S, Nargotra A, Koul S, Khan I . Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. J Antimicrob Chemother. 2010; 65(8):1694-701. DOI: 10.1093/jac/dkq186. View

Holler J, Slotved H, Molgaard P, Olsen C, Christensen S . Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles. Bioorg Med Chem. 2012; 20(14):4514-21. DOI: 10.1016/j.bmc.2012.05.025. View

Gupta V, Tiwari N, Gupta P, Verma S, Pal A, Srivastava S . A clerodane diterpene from Polyalthia longifolia as a modifying agent of the resistance of methicillin resistant Staphylococcus aureus. Phytomedicine. 2016; 23(6):654-61. DOI: 10.1016/j.phymed.2016.03.001. View

Song Y, Qin R, Pan X, OuYang Q, Liu T, Zhai Z . Design of New Antibacterial Enhancers Based on AcrB's Structure and the Evaluation of Their Antibacterial Enhancement Activity. Int J Mol Sci. 2016; 17(11). PMC: 5133929. DOI: 10.3390/ijms17111934. View

Chan B, Ip M, Gong H, Lui S, See R, Jolivalt C . Synergistic effects of diosmetin with erythromycin against ABC transporter over-expressed methicillin-resistant Staphylococcus aureus (MRSA) RN4220/pUL5054 and inhibition of MRSA pyruvate kinase. Phytomedicine. 2013; 20(7):611-4. DOI: 10.1016/j.phymed.2013.02.007. View

Falcao-Silva V, Silva D, Souza M, Siqueira-Junior J . Modulation of drug resistance in Staphylococcus aureus by a kaempferol glycoside from Herissantia tiubae (Malvaceae). Phytother Res. 2009; 23(10):1367-70. DOI: 10.1002/ptr.2695. View

Handzlik J, Szymanska E, Alibert S, Chevalier J, Otrebska E, Pekala E . Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin. Bioorg Med Chem. 2012; 21(1):135-45. DOI: 10.1016/j.bmc.2012.10.053. View

Piddock L . Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev. 2006; 19(2):382-402. PMC: 1471989. DOI: 10.1128/CMR.19.2.382-402.2006. View

10.

Lee M, Galazzo J, Staley A, Lee J, Warren M, Fuernkranz H . Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. Farmaco. 2001; 56(1-2):81-5. DOI: 10.1016/s0014-827x(01)01002-3. View

11.

Fazly Bazzaz B, Iranshahi M, Naderinasab M, Hajian S, Sabeti Z, Masumi E . Evaluation of the effects of galbanic acid from Ferula szowitsiana and conferol from F. badrakema, as modulators of multi-drug resistance in clinical isolates of Escherichia coli and Staphylococcus aureus. Res Pharm Sci. 2011; 5(1):21-8. PMC: 3093094. View

12.

Piddock L, Garvey M, Rahman M, Gibbons S . Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria. J Antimicrob Chemother. 2010; 65(6):1215-23. DOI: 10.1093/jac/dkq079. View

13.

Schindler B, Jacinto P, Kaatz G . Inhibition of drug efflux pumps in Staphylococcus aureus: current status of potentiating existing antibiotics. Future Microbiol. 2013; 8(4):491-507. DOI: 10.2217/fmb.13.16. View

14.

Roy S, Pahwa S, Nandanwar H, Jachak S . Phenylpropanoids of Alpinia galanga as efflux pump inhibitors in Mycobacterium smegmatis mc² 155. Fitoterapia. 2012; 83(7):1248-55. DOI: 10.1016/j.fitote.2012.06.008. View

15.

Haynes K, Abdali N, Jhawar V, Zgurskaya H, Parks J, Green A . Identification and Structure-Activity Relationships of Novel Compounds that Potentiate the Activities of Antibiotics in Escherichia coli. J Med Chem. 2017; 60(14):6205-6219. PMC: 5783635. DOI: 10.1021/acs.jmedchem.7b00453. View

16.

Smith E, Kaatz G, Seo S, Wareham N, Williamson E, Gibbons S . The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother. 2007; 51(12):4480-3. PMC: 2168009. DOI: 10.1128/AAC.00216-07. View

17.

Stavri M, Piddock L, Gibbons S . Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother. 2006; 59(6):1247-60. DOI: 10.1093/jac/dkl460. View

18.

Kalia N, Mahajan P, Mehra R, Nargotra A, Sharma J, Koul S . Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus. J Antimicrob Chemother. 2012; 67(10):2401-8. DOI: 10.1093/jac/dks232. View

19.

Nakajima A, Sugimoto Y, Yoneyama H, Nakae T . High-level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation. Microbiol Immunol. 2002; 46(6):391-5. DOI: 10.1111/j.1348-0421.2002.tb02711.x. View

20.

Siriyong T, Srimanote P, Chusri S, Yingyongnarongkul B, Suaisom C, Tipmanee V . Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa. BMC Complement Altern Med. 2017; 17(1):405. PMC: 5557310. DOI: 10.1186/s12906-017-1913-y. View